AdaptHealth Overview
Valuation check: AHCO's ROE is -5.42%, below the Industrials sector average of 20.56%.
Get informed when a big investor buys or sells
+ Follow-5.42%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
AdaptHealth (AHCO) currently reports a ROE of -5.42%. That is below the Industrials sector average of 20.56%. Use the charts on this page to explore AdaptHealth's ROE history and peer comparisons.
AdaptHealth's ROE of -5.42% is lower than the Industrials sector average of 20.56%. That is roughly 126.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but AdaptHealth's current -5.42% should be judged against Industrials norms (sector average: 20.56%) and against AHCO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -5.42%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is 20.56%. From there, open related valuation or income-statement pages for AdaptHealth, and consider following AHCO for alerts when major investors trade the stock.
AdaptHealth is classified in the Industrials sector. On ROE, it currently shows -5.42% versus a sector average near 20.56%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing AHCO with unrelated industries.
